KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Operating Leases: 2020-2025

Historic Operating Leases for Adaptive Biotechnologies (ADPT) over the last 6 years, with Sep 2025 value amounting to $72.4 million.

  • Adaptive Biotechnologies' Operating Leases fell 11.54% to $72.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.4 million, marking a year-over-year decrease of 11.54%. This contributed to the annual value of $79.1 million for FY2024, which is 11.46% down from last year.
  • Per Adaptive Biotechnologies' latest filing, its Operating Leases stood at $72.4 million for Q3 2025, which was down 2.76% from $74.4 million recorded in Q2 2025.
  • In the past 5 years, Adaptive Biotechnologies' Operating Leases registered a high of $108.0 million during Q3 2021, and its lowest value of $72.4 million during Q3 2025.
  • For the 3-year period, Adaptive Biotechnologies' Operating Leases averaged around $84.3 million, with its median value being $84.4 million (2024).
  • In the last 5 years, Adaptive Biotechnologies' Operating Leases skyrocketed by 160.64% in 2021 and then declined by 12.04% in 2025.
  • Over the past 5 years, Adaptive Biotechnologies' Operating Leases (Quarterly) stood at $106.7 million in 2021, then decreased by 7.42% to $98.8 million in 2022, then fell by 9.50% to $89.4 million in 2023, then declined by 11.46% to $79.1 million in 2024, then decreased by 11.54% to $72.4 million in 2025.
  • Its Operating Leases was $72.4 million in Q3 2025, compared to $74.4 million in Q2 2025 and $76.4 million in Q1 2025.